Akron General Medical Center

Akron General Medical Center was paid $98.99M by Medicaid between Jan 2018 and Dec 2024, across 666 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 17% of everything it billed.

33Billing provider infoAKRON GENERAL MEDICAL CENTER
AKRON, OH 44307

33aNPI1821035940assigned 05/31/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$98.99M

24GClaims2,090,000

24DCodes billed666

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#9 of 101

Median peer was paid$22.32M

This provider vs. median4.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	116,158	$4.46M
2019	120,864	$5.14M
2020	105,346	$5.79M
2021	153,455	$7.18M
2022	197,225	$9.14M
2023	817,119	$41.09M
2024incomplete	579,833	$26.20M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	17%	180,297	149,738	$16.63M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.4%	65,690	55,088	$9.31M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.8%	65,598	59,755	$7.71M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.8%	59,870	51,885	$7.70M
96361	Intravenous infusion, hydration; each additional hour	7.3%	21,651	13,842	$7.21M
J9271	Injection, pembrolizumab, 1 mg	3.4%	449	247	$3.38M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.9%	36,465	14,824	$2.86M
70450	Computed tomography, head or brain; without contrast material	2.3%	8,547	6,641	$2.28M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	8,990	6,772	$2.19M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1.6%	987	253	$1.63M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.3%	5,533	2,549	$1.31M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	9,583	5,635	$1.30M

654 more codes

90853	Group psychotherapy (other than of a multiple-family group)	1.3%	12,182	$1.26M
G0378	Hospital observation service, per hour	1.2%	14,891	$1.21M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	8,252	$925K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	7,037	$923K
80053	Comprehensive metabolic panel	<1%	82,220	$831K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,873	$819K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,271	$806K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,738	$765K
20610		<1%	4,360	$709K
95886		<1%	2,534	$691K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	15,457	$599K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,558	$591K
98941	Chiropractic manipulative treatment; spinal, 3-4 regions	<1%	10,253	$564K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	655	$562K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,203	$562K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	4,290	$509K
20553		<1%	3,266	$456K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,349	$436K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	825	$385K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	15,462	$343K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,269	$333K
62323		<1%	788	$328K
90837	Psychotherapy session, about an hour	<1%	2,233	$323K
59025	Fetal non-stress test	<1%	1,933	$318K
64493		<1%	438	$312K
84443	Thyroid stimulating hormone (TSH)	<1%	21,777	$304K
70498		<1%	1,001	$303K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	2,462	$300K
97810		<1%	8,680	$294K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,000	$279K
52000		<1%	474	$276K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	114,566	$273K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	6,761	$273K
97113		<1%	3,468	$261K
36415	Collection of venous blood by venipuncture	<1%	169,906	$253K
71046	Radiologic examination, chest; 2 views	<1%	19,916	$252K
96415		<1%	930	$249K
78815	Positron emission tomography (PET) for limited area imaging	<1%	388	$245K
80048	Basic metabolic panel (calcium, ionized)	<1%	35,029	$240K
70491		<1%	745	$237K
97161		<1%	5,190	$231K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	7,758	$229K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,858	$223K
96127		<1%	3,941	$222K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	10,782	$210K
99232	Hospital visit by a doctor, follow-up day	<1%	12,130	$197K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	9,670	$187K
76642		<1%	1,478	$187K
99213	Doctor's office visit, returning patient (routine)	<1%	4,415	$181K
97535	Self-care/home management training, each 15 minutes	<1%	5,083	$178K
90791	Psychiatric diagnostic evaluation	<1%	886	$177K
80061	Lipid panel	<1%	14,247	$176K
76770		<1%	1,087	$172K
90870		<1%	401	$163K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	723	$162K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	951	$158K
97597		<1%	2,711	$158K
86850		<1%	6,071	$153K
C1776	Joint device (implantable)	<1%	96	$152K
71250		<1%	1,556	$148K
87086	Culture, bacterial; quantitative colony count, urine	<1%	16,136	$147K
85027		<1%	24,742	$146K
97811		<1%	8,569	$146K
93975		<1%	1,520	$143K
76536		<1%	1,336	$142K
86780		<1%	5,543	$139K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,471	$137K
64483		<1%	280	$135K
88142		<1%	6,422	$134K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,253	$132K
93971		<1%	1,757	$132K
84702		<1%	5,788	$130K
J0897	Injection, denosumab, 1 mg	<1%	156	$127K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,030	$126K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	820	$126K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	91	$125K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,619	$123K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	539	$121K
83036	Hemoglobin; glycosylated (A1C)	<1%	16,275	$121K
49083		<1%	261	$120K
90677		<1%	753	$117K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,355	$115K
72141		<1%	661	$114K
93970		<1%	796	$114K
76801		<1%	823	$114K
96367		<1%	1,961	$113K
84439		<1%	7,672	$113K
64635		<1%	175	$109K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,059	$105K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,012	$105K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,280	$105K
95811		<1%	175	$104K
93017		<1%	1,171	$102K
74183		<1%	448	$102K
12001		<1%	627	$99K
76830	Ultrasound, transvaginal	<1%	1,409	$99K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	6,039	$99K
71275	Computed tomographic angiography, chest, with contrast material	<1%	322	$98K
82607		<1%	5,061	$94K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	679	$93K
97802		<1%	1,364	$93K
20550		<1%	589	$92K
86140		<1%	7,704	$91K
93321		<1%	520	$90K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	352	$89K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,491	$87K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	770	$87K
73221		<1%	418	$86K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,252	$86K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	304	$84K
86803		<1%	4,513	$84K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	644	$83K
86900		<1%	6,128	$82K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,624	$81K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	905	$78K
82728		<1%	5,758	$78K
72100		<1%	2,943	$78K
10060		<1%	487	$78K
97165		<1%	1,361	$77K
87808		<1%	5,933	$77K
72131		<1%	910	$75K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	592	$74K
81513		<1%	626	$73K
93325		<1%	801	$73K
73630		<1%	4,331	$70K
97162		<1%	2,030	$69K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,192	$69K
87905		<1%	6,131	$65K
73030		<1%	3,439	$65K
87340		<1%	3,052	$62K
93798		<1%	1,061	$62K
73130		<1%	3,297	$61K
88307		<1%	575	$60K
94060		<1%	460	$57K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	85	$57K
86762		<1%	1,861	$56K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,196	$56K
70486		<1%	1,033	$54K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	31,488	$53K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	298	$53K
93308		<1%	188	$52K
83970		<1%	1,905	$50K
77336		<1%	499	$49K
J1756	Injection, iron sucrose, 1 mg	<1%	1,862	$49K
84484		<1%	21,153	$48K
36430		<1%	418	$48K
80074		<1%	2,005	$47K
87631		<1%	266	$47K
19083		<1%	48	$46K
78264		<1%	222	$46K
83540		<1%	5,132	$45K
73610		<1%	3,077	$45K
Q3014	Telehealth originating site facility fee	<1%	1,892	$44K
72050		<1%	1,286	$44K
73564		<1%	2,035	$44K
81001		<1%	55,183	$43K
72110		<1%	1,178	$42K
86901		<1%	6,129	$41K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,152	$40K
27096		<1%	99	$40K
62321		<1%	79	$39K
83992		<1%	1,661	$39K
0002A		<1%	1,034	$39K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	14,803	$39K
74018		<1%	1,394	$39K
82570		<1%	4,692	$38K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	3,755	$38K
0001A		<1%	1,082	$38K
12002		<1%	247	$37K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	1,978	$37K
97166		<1%	845	$37K
80076		<1%	4,038	$37K
99203	Doctor's office visit, new patient (routine)	<1%	1,577	$37K
77080		<1%	568	$36K
87210		<1%	1,698	$36K
74174		<1%	390	$36K
76813		<1%	434	$35K
98940		<1%	599	$35K
83550		<1%	5,076	$35K
73110		<1%	2,205	$35K
72040		<1%	922	$34K
94726		<1%	521	$34K
93296		<1%	1,915	$33K
73502		<1%	1,807	$33K
90715		<1%	2,262	$32K
83735		<1%	13,417	$32K
87653		<1%	997	$32K
70496		<1%	1,079	$30K
94729		<1%	604	$30K
86038		<1%	1,491	$29K
87077		<1%	4,449	$29K
86480		<1%	859	$29K
73560		<1%	1,884	$29K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	25,897	$28K
20600		<1%	145	$28K
99214	Doctor's office visit, returning patient (more involved)	<1%	846	$28K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	49	$28K
86592		<1%	1,032	$27K
97803		<1%	362	$26K
77062		<1%	745	$26K
80345		<1%	1,661	$26K
90834	Psychotherapy session, about 45 minutes	<1%	161	$26K
82962		<1%	13,578	$26K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,522	$26K
97116		<1%	1,251	$25K
76857		<1%	1,374	$25K
90688		<1%	1,446	$25K
76882		<1%	266	$25K
82784		<1%	1,899	$25K
85610		<1%	6,395	$24K
87522	Neg quan hep c or qual rna	<1%	789	$24K
82805		<1%	838	$24K
77061		<1%	608	$24K
85652		<1%	7,168	$23K
99152		<1%	663	$23K
80197		<1%	1,576	$23K
64450		<1%	117	$23K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,602	$21K
55250		<1%	14	$20K
73700		<1%	179	$20K
93246		<1%	259	$20K
74178		<1%	79	$20K
71045	Radiologic examination, chest; single view	<1%	6,300	$20K
84153		<1%	1,421	$19K
82746		<1%	2,413	$19K
86706		<1%	1,183	$19K
95813		<1%	17	$19K
77300		<1%	45	$18K
73140		<1%	1,007	$18K
87497		<1%	689	$18K
74019		<1%	460	$17K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,320	$17K
77065	Tomosynthesis, mammo	<1%	900	$17K
96523		<1%	416	$17K
80069		<1%	1,167	$17K
82043		<1%	2,932	$17K
96368		<1%	709	$16K
95913		<1%	129	$16K
97164		<1%	256	$16K
86364		<1%	842	$16K
84481		<1%	1,727	$16K
72170		<1%	1,455	$15K
84403		<1%	1,007	$15K
80346		<1%	1,705	$15K
80348		<1%	1,675	$15K
95819		<1%	90	$15K
72128		<1%	325	$15K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	159	$15K
80349		<1%	1,660	$14K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	602	$14K
72070		<1%	483	$14K
80353		<1%	1,661	$14K
51705		<1%	173	$14K
86703		<1%	926	$14K
72072		<1%	593	$14K
84146		<1%	754	$14K
93923		<1%	152	$13K
82565		<1%	1,460	$13K
80361		<1%	1,661	$13K
80356		<1%	1,661	$13K
80358		<1%	1,661	$13K
80359		<1%	1,661	$12K
84630		<1%	796	$12K
86431		<1%	1,192	$12K
70544		<1%	153	$12K
83880		<1%	2,772	$12K
82550		<1%	4,280	$12K
82950		<1%	830	$12K
93270		<1%	130	$12K
20605		<1%	67	$12K
81025		<1%	20,566	$11K
72158		<1%	71	$11K
87102		<1%	740	$11K
71271		<1%	59	$11K
83690		<1%	15,053	$11K
72197		<1%	44	$11K
86147		<1%	333	$11K
84100		<1%	2,930	$11K
86704		<1%	787	$11K
86200		<1%	984	$11K
82670		<1%	483	$11K
96376		<1%	5,686	$10K
87186		<1%	3,156	$10K
20526		<1%	60	$10K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	985	$10K
73590		<1%	997	$10K
51798		<1%	1,442	$10K
73562		<1%	989	$10K
82533		<1%	462	$10K
87640		<1%	487	$10K
86235		<1%	720	$10K
91320		<1%	207	$10K
88304		<1%	771	$10K
93880		<1%	108	$10K
83001		<1%	581	$10K
12011		<1%	62	$9K
96116		<1%	64	$9K
86258		<1%	347	$9K
84425		<1%	920	$9K
77334		<1%	31	$9K
10005		<1%	17	$9K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	26	$9K
J2997	Injection, alteplase recombinant, 1 mg	<1%	59	$9K
88341		<1%	110	$9K
71101		<1%	650	$9K
99153	Mod sedat endo service >5yrs	<1%	394	$9K
87641		<1%	488	$8K
99221		<1%	442	$8K
88342		<1%	795	$8K
93225		<1%	56	$8K
73552		<1%	611	$8K
82627		<1%	308	$8K
99252		<1%	281	$8K
96375	Therapeutic injection; each additional sequential IV push	<1%	15,363	$8K
90792	Psychiatric diagnostic evaluation with medical services	<1%	40	$8K
77066	Tomosynthesis, mammo	<1%	827	$8K
86225		<1%	917	$8K
84156		<1%	1,922	$8K
80321		<1%	438	$8K
87070		<1%	1,261	$8K
90651		<1%	43	$8K
74220		<1%	118	$7K
83516		<1%	358	$7K
87493		<1%	294	$7K
86376		<1%	461	$7K
99406		<1%	238	$7K
73080		<1%	824	$7K
87799		<1%	414	$7K
73070		<1%	337	$7K
72114		<1%	152	$6K
82330		<1%	3,404	$6K
82977		<1%	754	$6K
95816		<1%	46	$6K
84480		<1%	541	$6K
95910		<1%	96	$6K
28470		<1%	21	$6K
96130		<1%	34	$6K
0124A		<1%	230	$6K
80323		<1%	319	$6K
84402		<1%	374	$6K
76825		<1%	90	$6K
73090		<1%	577	$6K
83020		<1%	300	$6K
81596		<1%	34	$5K
83525		<1%	242	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,483	$5K
76870		<1%	415	$5K
J1750	Injection, iron dextran, 50 mg	<1%	35	$5K
72200		<1%	191	$5K
81003		<1%	7,245	$5K
82105		<1%	345	$5K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,013	$5K
93299		<1%	272	$5K
84550		<1%	886	$5K
97014		<1%	137	$5K
74246		<1%	35	$5K
86160		<1%	629	$5K
83002		<1%	377	$5K
99215	Doctor's office visit, returning patient (complex)	<1%	92	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	340	$5K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,035	$5K
82077		<1%	4,387	$5K
77002		<1%	330	$5K
84460		<1%	531	$5K
83993		<1%	281	$4K
86800		<1%	423	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,005	$4K
84590		<1%	429	$4K
00104		<1%	395	$4K
85730		<1%	2,841	$4K
90480		<1%	207	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	20,234	$4K
72156		<1%	40	$4K
76821		<1%	93	$4K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	248	$4K
84703		<1%	3,556	$4K
90658		<1%	417	$4K
86039		<1%	328	$4K
99204	Doctor's office visit, new patient (more involved)	<1%	122	$4K
87400		<1%	166	$4K
20552		<1%	25	$4K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	409	$4K
78227		<1%	16	$4K
80164		<1%	566	$4K
94010		<1%	70	$3K
51784		<1%	13	$3K
86923		<1%	156	$3K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	44	$3K
83615		<1%	746	$3K
36593		<1%	17	$3K
93298		<1%	331	$3K
86787		<1%	171	$3K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	17	$3K
00731		<1%	1,272	$3K
11721		<1%	192	$3K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	43	$3K
83521		<1%	416	$3K
85379		<1%	2,655	$3K
76820		<1%	78	$3K
83605		<1%	5,320	$3K
76827		<1%	89	$3K
J3490	Unclassified drugs	<1%	898	$3K
87205		<1%	1,163	$3K
82947		<1%	3,176	$3K
73060		<1%	347	$3K
80143		<1%	2,619	$3K
82653		<1%	121	$3K
73523		<1%	97	$3K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,462	$3K
87481		<1%	296	$3K
73565		<1%	204	$2K
90832	Psychotherapy session, about 30 minutes	<1%	20	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	12	$2K
36591		<1%	405	$2K
96132		<1%	31	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	71	$2K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	777	$2K
86308		<1%	500	$2K
84132		<1%	3,419	$2K
84155		<1%	601	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,413	$2K
96416		<1%	62	$2K
J1815	Injection, insulin, per 5 units	<1%	246	$2K
64636		<1%	173	$2K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	12	$2K
96136		<1%	32	$2K
84165		<1%	463	$2K
82040		<1%	250	$2K
83520		<1%	59	$2K
85045		<1%	684	$2K
86146		<1%	172	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,777	$2K
82103		<1%	160	$2K
87338		<1%	100	$2K
96146		<1%	14	$2K
90746		<1%	116	$2K
86705		<1%	43	$2K
J3489	Injection, zoledronic acid, 1 mg	<1%	104	$2K
87040		<1%	1,657	$2K
85018		<1%	1,235	$2K
86334		<1%	115	$2K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	90	$2K
90739		<1%	138	$2K
97012		<1%	34	$2K
96402		<1%	171	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	16,239	$1K
76942		<1%	361	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	535	$1K
82951		<1%	55	$1K
85014		<1%	255	$1K
97032		<1%	24	$1K
80179		<1%	2,570	$1K
93922		<1%	14	$1K
72146		<1%	12	$1K
82378		<1%	187	$1K
82150		<1%	233	$1K
87536		<1%	42	$1K
86317		<1%	50	$1K
80178		<1%	180	$1K
82375		<1%	2,773	$1K
99401		<1%	16	$1K
82310		<1%	149	$1K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	839	$1K
84134		<1%	112	$1K
C9113	Injection, pantoprazole sodium, per vial	<1%	697	$1K
80177		<1%	208	$1K
86256		<1%	63	$1K
90662		<1%	192	$1K
99253		<1%	32	$1K
86695		<1%	50	$1K
82803		<1%	2,036	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,707	$1K
94618		<1%	14	$1K
00840		<1%	413	$1K
86709		<1%	59	$995.60
51729		<1%	13	$979.78
86708		<1%	37	$969.64
J1453	Injection, fosaprepitant, 1 mg	<1%	79	$958.85
J9045	Injection, carboplatin, 50 mg	<1%	109	$958.58
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	110	$954.49
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,185	$953.87
73600		<1%	83	$925.76
82785		<1%	82	$922.13
87045		<1%	52	$896.26
85041		<1%	251	$894.50
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	4,475	$879.57
99222	Initial hospital care, per day, moderate complexity	<1%	25	$857.12
77091		<1%	39	$838.80
86359		<1%	18	$817.49
J1790	Injection, droperidol, up to 5 mg	<1%	1,663	$808.89
83050		<1%	2,408	$803.60
86696		<1%	50	$795.73
80354		<1%	825	$786.59
99254		<1%	13	$712.83
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	399	$711.76
84295		<1%	2,951	$709.46
76818		<1%	17	$700.05
64494		<1%	420	$699.85
76937		<1%	74	$694.66
J2704	Injection, propofol, 10 mg	<1%	9,494	$693.06
84270		<1%	43	$678.02
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	7,706	$674.84
82435		<1%	2,005	$666.87
73000		<1%	28	$655.53
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,896	$623.38
82248		<1%	65	$621.07
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	258	$620.81
85613		<1%	39	$610.07
90686		<1%	48	$605.02
87529		<1%	17	$598.50
86765		<1%	30	$598.46
51700		<1%	24	$572.76
J3370	Injection, vancomycin hcl, 500 mg	<1%	890	$571.50
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,443	$568.68
84445		<1%	14	$517.13
72220		<1%	30	$494.80
82525		<1%	47	$475.03
86735		<1%	22	$468.84
87449		<1%	56	$465.57
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	31	$465.45
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	9,381	$464.81
87046		<1%	52	$448.88
77001		<1%	64	$446.48
95909		<1%	25	$437.91
82140		<1%	91	$435.21
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,321	$434.38
90461		<1%	47	$423.73
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	18	$412.85
84144		<1%	12	$377.65
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	16,994	$376.93
82952		<1%	25	$362.79
00811		<1%	148	$362.46
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	137	$356.42
86361		<1%	13	$349.78
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,961	$346.72
73501		<1%	40	$336.60
99225		<1%	28	$331.27
84145		<1%	88	$326.09
51701		<1%	17	$323.02
92610		<1%	13	$309.91
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,611	$309.33
82390		<1%	17	$303.99
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,452	$290.06
85384		<1%	73	$289.43
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,869	$285.86
87328		<1%	17	$276.22
51797		<1%	13	$267.33
88311		<1%	73	$257.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	973	$247.05
J2785	Injection, regadenoson, 0.1 mg	<1%	756	$244.60
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,465	$230.70
84681		<1%	14	$218.54
73660		<1%	13	$216.75
84207		<1%	18	$215.39
84450		<1%	46	$213.46
82010		<1%	387	$210.81
83090		<1%	20	$204.51
80175		<1%	16	$190.97
96417		<1%	808	$184.55
J0694	Injection, cefoxitin sodium, 1 gm	<1%	77	$179.94
95912		<1%	40	$168.32
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	242	$156.49
J2060	Injection, lorazepam, 2 mg	<1%	1,293	$154.89
82274		<1%	22	$151.63
83721		<1%	48	$149.60
95911		<1%	40	$148.63
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,715	$146.73
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	720	$137.36
J1940	Injection, furosemide, up to 20 mg	<1%	628	$134.79
87075		<1%	73	$132.76
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	465	$130.46
88112		<1%	98	$126.43
86301		<1%	21	$126.16
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,696	$126.01
86790		<1%	31	$124.56
87329		<1%	17	$119.32
82747		<1%	13	$112.56
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	152	$110.57
84075		<1%	14	$103.00
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,677	$97.60
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	696	$97.13
96139		<1%	13	$85.06
80047		<1%	28	$84.40
88173		<1%	28	$81.99
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,196	$80.56
J3411	Injection, thiamine hcl, 100 mg	<1%	70	$79.80
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	2,828	$69.01
81002		<1%	61	$68.73
86381		<1%	14	$67.06
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,873	$66.50
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	477	$65.67
J3480	Injection, potassium chloride, per 2 meq	<1%	1,016	$63.36
86304		<1%	20	$58.43
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	13	$53.88
82365		<1%	40	$50.70
88302		<1%	15	$45.62
J1171	Injection, hydromorphone, 0.1 mg	<1%	221	$37.48
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	222	$36.48
J2470	Injection, pantoprazole sodium, 40 mg	<1%	111	$35.08
A9270	Non-covered item or service	<1%	2,422	$33.50
86255		<1%	25	$29.61
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	131	$25.15
C9290	Injection, bupivacaine liposome, 1 mg	<1%	27	$23.52
91300		<1%	2,122	$20.80
J7050	Infusion, normal saline solution, 250 cc	<1%	4,905	$19.45
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	162	$17.98
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	506	$17.37
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	211	$13.20
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	847	$11.97
J1630	Injection, haloperidol, up to 5 mg	<1%	77	$11.94
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	103	$10.37
85007		<1%	14	$9.45
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	27	$8.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	254	$5.97
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	62	$5.09
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	245	$3.72
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	233	$3.60
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	1,784	$2.94
J0456	Injection, azithromycin, 500 mg	<1%	46	$2.72
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	72	$2.68
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,055	$1.18
91312		<1%	104	$0.73
C1769	Guide wire	0%	996	$0.00
76377		0%	130	$0.00
3074F		0%	459	$0.00
01480		0%	16	$0.00
94760		0%	1,212	$0.00
00813		0%	63	$0.00
3079F		0%	57	$0.00
G0008	Administration of influenza virus vaccine	0%	252	$0.00
64484		0%	45	$0.00
A4648	Tissue marker, implantable, any type, each	0%	270	$0.00
36416		0%	99	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	83	$0.00
87081		0%	32	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	190	$0.00
00790		0%	147	$0.00
96411		0%	93	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	33	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	38	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	16	$0.00
3078F		0%	359	$0.00
0598T		0%	18	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	520	$0.00
00910		0%	43	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	60	$0.00
00918		0%	20	$0.00
00400		0%	54	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	33	$0.00
51741		0%	13	$0.00
96133		0%	15	$0.00
C2625	Stent, non-coronary, temporary, with delivery system	0%	33	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	128	$0.00
C1788	Port, indwelling (implantable)	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)

Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Provider	Location	Paid
The Cleveland Clinic Foundation	Cleveland, OH	$863.55M
Cleveland Clinic Mercy Hospital	Canton, OH	$86.97M
Memorial Hermann Health System	Houston, TX	$84.45M
Fairview Hospital	Cleveland, OH	$62.42M
Lutheran Hospital	Cleveland, OH	$41.49M
Cleveland Clinic Health System - East Region	Euclid, OH	$40.67M
Memorial Hermann Health System	Houston, TX	$39.46M
Cleveland Clinic Children's Hospital for Rehabilitation	Cleveland, OH	$36.43M
Cleveland Clinic Health System - East Region	Mayfield Hts, OH	$32.76M
Cleveland Clinic Health System - East Region	Warrensville Heights, OH	$31.44M
Partners Physician Group	Akron, OH	$28.37M
Marymount Hospital INC	Garfield Heights, OH	$28.02M
Memorial Hermann Health System	Humble, TX	$26.79M
Martin Memorial Medical Center INC	Stuart, FL	$26.03M
The Union Hospital Association	Dover, OH	$20.23M
Lodi Community Hospital	Lodi, OH	$17.53M
Clinic Medical Services Company LLC	Cleveland, OH	$10.82M
Cleveland Clinic Home Care Services	Independence, OH	$10.76M
Indian River Memorial Hospital INC	Vero Beach, FL	$9.27M
Memorial Hermann Health System	Sugar Land, TX	$9.14M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.